Home / National / First-ever phase-three clinical trial for dengue vaccine initiated in India

First-ever phase-three clinical trial for dengue vaccine initiated in India

The indigenous vaccine, DengiAll, has been developed by Panacea Biotec; the phase 3 clinical trial is being conducted by ICMR and the pharma company on over 10,000 participants across 18 States
Share this news

About @click197 - B TELEGRAM BAM 423 751 RUB TINKOFF

Check Also

अध्यात्म को एआई तकनीक  के साथ जोड़कर चमत्कार  किए जा सकते हैं-डॉ. उमर अली शाह

भीमली। श्री विश्व विज्ञान विद्या आध्यात्मिक पीठ के नौंवे पीठधिपति सद्गुरु डॉ. उमर अली शाह …